Business
Video abstract published endorsing Speedboat
Video abstract published endorsing Speedboat.
About this update from Creo Medical Group Plc
[{"type":"text","content":"\n \n \n RNS Number : 8502U\n Creo Medical Group PLC\n 03 August 2020\n \n \n \n \n Creo Medical Group plc\n \n \n (\"Creo\" or the \"Company\")\n \n \n \n \n \n Video abstract published endorsing Speedboat procedure \n \n \n \n \n Creo Medical Group plc (AIM: CREO), the medical device company, focused on the emerging field of surgical endoscopy, announces that early experience of the Company's Speedboat™ Inject device has shown that it is feasible for performing peroral endoscopic myotomy (POEM) with a good safety profile. The abstract was authored by experts in the field of Gastrointestinal ('GI') therapeutics endoscopy, including Dr. Amit Maydeo an internationally renowned Gastroenterologist and endoscopy expert, known for his pioneering efforts on therapeutic endoscopy.\n \n The main advantages of using Speedboat Inject were highlighted as reducing the risk of injury to the mucosa by the orientation of the hull and use of bipolar radiofrequency, which then aided quick tissue healing and resulted in quicker post-procedural recovery. Speedboat also reduced the overall procedure time, as no device changes were needed for bleeding vessels.\n \n \n The video abstract, published via\n an open access content publisher, Thieme Group titled: 'Feasibility of Speedboat RS2 with bipolar radiofrequency energy for peroral endoscopic myotomy in patients with achalasia (with video)' can be viewed online here:\n \n \n https://www.thieme-connect.com/products/ejournals/html/10.1055/a-1165-0087\n \n \n \n \n \n Dr Amit Maydeo, Chairman & Chief of Gastroenterology & Therapeutic Endoscopy at the Baldota Institute of Digestive Sciences at the Global hospital in Mumbai, commented:\n \n \"Our center has been performing POEM for almost a decade and diverticular POEM, and the advent of Speedboat Inject, has certainly opened up new avenues in submucosal endoscopy. We feel the advanced technology of Speedboat overcome many of the problems faced in routine third space procedures. Although the economics of it currently remain unexplored, the device certainly looks to make a huge impact in terms of its advantages over currently existing standard accessories in POEM.\"\n \n \n \n \n \n \n \n Craig Gulliford, Chief Executive Officer, commented:\n \n \"We are pleased to see the Speedboat device...